MURA – Mural Oncology plc

Float Short %

2.62

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

EPS Last/This Y

1.92

EPS This/Next Y

5.27

Price

Target Price

Analyst Recom

Performance Q

-1.45

Relative Volume

Beta

2.95

Ticker: MURA

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	MURA	2.09	0.25	0.00	24841
2025-11-11	MURA	2.09	0.25	0.00	24841
2025-11-12	MURA	2.09	0.25	0.00	24841
2025-11-13	MURA	2.09	0.25	0.00	24841
2025-11-14	MURA	2.09	0.25	0.00	24841
2025-11-17	MURA	2.09	0.25	0.00	24842
2025-11-18	MURA	2.08	0.25	10.00	24893
2025-11-19	MURA	2.08	0.25	10.00	24893
2025-11-20	MURA	2.1	0.25	10.00	24893
2025-11-21	MURA	2.1	0.25	10.00	24893
2025-11-24	MURA	2.09	0.25	10.00	24893
2025-11-25	MURA	2.09	0.26	0.00	25113
2025-11-26	MURA	2.03	0.26	0.00	25113
2025-12-01	MURA	2.03	0.26	0.00	25114
2025-12-02	MURA	2.03	0.26	999.99	25115
2025-12-03	MURA	2.035	0.26	999.99	25115
2025-12-04	MURA	2.04	0.26	999.99	25116
2025-12-05	MURA	2.04	0.26	999.99	25116
2025-12-08	MURA	2.04	0.26	999.99	25116
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	MURA	2.10	68.5	-	-5.66
2025-11-11	MURA	2.10	68.5	-	-5.66
2025-11-12	MURA	2.08	68.5	-	-5.66
2025-11-13	MURA	2.09	68.5	-	-5.66
2025-11-14	MURA	2.09	81.6	-	-5.66
2025-11-17	MURA	2.09	81.6	-	-5.66
2025-11-18	MURA	2.09	81.6	-	-5.66
2025-11-19	MURA	2.08	81.6	-	-5.66
2025-11-20	MURA	2.09	81.6	-	-5.66
2025-11-21	MURA	2.10	81.6	-	-5.66
2025-11-24	MURA	2.09	81.6	-	-5.66
2025-11-25	MURA	2.10	81.6	-	-5.66
2025-11-26	MURA	2.03	81.6	-	-5.66
2025-12-01	MURA	2.03	81.6	-	-5.66
2025-12-02	MURA	2.03	81.6	-	-5.66
2025-12-03	MURA	2.04	81.6	-	-5.66
2025-12-04	MURA	2.03	81.6	-	-5.66
2025-12-05	MURA	0.00	81.6	-	-5.66
2025-12-08	MURA	0.00	81.6	-	-5.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	MURA	-0.37	-9.69	2.96
2025-11-11	MURA	-0.99	-9.69	2.96
2025-11-12	MURA	-0.99	-9.69	2.84
2025-11-13	MURA	-0.99	-9.69	2.84
2025-11-14	MURA	-0.99	-9.69	2.86
2025-11-17	MURA	-0.96	-2.15	2.68
2025-11-18	MURA	-1.40	-2.15	2.68
2025-11-19	MURA	-1.40	-2.15	2.68
2025-11-20	MURA	-1.40	-2.15	2.68
2025-11-21	MURA	-1.40	-2.15	2.68
2025-11-24	MURA	-1.40	-16.97	2.57
2025-11-25	MURA	-2.03	-16.97	2.57
2025-11-26	MURA	-2.03	-16.97	2.62
2025-12-01	MURA	-2.03	-16.89	2.62
2025-12-02	MURA	-2.03	-16.89	2.62
2025-12-03	MURA	-2.03	-16.89	2.62
2025-12-04	MURA	-2.03	-16.89	2.62
2025-12-05	MURA	-2.03	-16.89	2.62
2025-12-08	MURA	-2.03	-16.45	2.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.03

Institutional Transactions

-16.45

Beta

2.95

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

100

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

-5.66

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.7

Return on Equity vs Industry %

-227.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Mural Oncology plc

Sector: Healthcare

Industry: Biotechnology

Employees: 116

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland. As of December 4, 2025, Mural Oncology plc operates as a subsidiary of XOMA Royalty Corporation.

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

MDT – Medtronic Plc

Float Short %

1.06

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

0.33

EPS Last/This Y

0.16

EPS This/Next Y

0.46

Price

101.26

Target Price

111.12

Analyst Recom

2.12

Performance Q

7.64

Relative Volume

0.77

Beta

0.72

Ticker: MDT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	MDT	92.66	0.41	0.37	239175
2025-11-11	MDT	95.39	0.41	0.09	240189
2025-11-12	MDT	95.83	0.45	0.20	226351
2025-11-13	MDT	96.15	0.45	0.34	228449
2025-11-14	MDT	95.88	0.45	0.24	230195
2025-11-17	MDT	96.35	0.42	1.37	218002
2025-11-18	MDT	100.82	0.47	0.36	234385
2025-11-19	MDT	100.31	0.49	0.60	245841
2025-11-20	MDT	99.36	0.49	0.90	248415
2025-11-21	MDT	101.23	0.49	0.14	253304
2025-11-24	MDT	103.21	0.54	0.42	179900
2025-11-25	MDT	105.36	0.54	0.61	189992
2025-11-26	MDT	105.01	0.57	0.48	202954
2025-12-01	MDT	103.36	0.55	1.01	197325
2025-12-02	MDT	102.04	0.57	0.60	209235
2025-12-03	MDT	101.99	0.58	0.24	212240
2025-12-04	MDT	102.02	0.56	0.29	219908
2025-12-05	MDT	101.35	0.55	0.50	222921
2025-12-08	MDT	101.26	0.55	0.41	218903
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	MDT	92.66	4.3	892.0	5.62
2025-11-11	MDT	95.40	4.3	1044.3	5.62
2025-11-12	MDT	95.82	4.3	888.5	5.62
2025-11-13	MDT	96.12	4.3	881.6	5.62
2025-11-14	MDT	95.86	4.3	843.3	5.62
2025-11-17	MDT	96.36	4.3	892.9	5.62
2025-11-18	MDT	100.80	4.3	1153.5	5.62
2025-11-19	MDT	100.34	4.3	832.7	5.62
2025-11-20	MDT	99.36	-4.0	799.6	5.64
2025-11-21	MDT	101.20	-4.0	977.6	5.64
2025-11-24	MDT	103.23	-3.8	1014.9	5.64
2025-11-25	MDT	105.35	-3.8	1020.1	5.64
2025-11-26	MDT	105.02	-3.8	855.5	5.64
2025-12-01	MDT	103.38	-3.8	762.7	5.64
2025-12-02	MDT	102.03	-3.8	799.7	5.64
2025-12-03	MDT	101.97	-3.8	875.9	5.64
2025-12-04	MDT	102.02	-3.8	882.7	5.64
2025-12-05	MDT	101.36	-3.8	840.8	5.65
2025-12-08	MDT	101.26	-3.8	-	5.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	MDT	-0.35	-0.40	1.17
2025-11-11	MDT	-0.35	-0.40	1.17
2025-11-12	MDT	-0.35	-0.40	1.13
2025-11-13	MDT	-0.35	-0.40	1.13
2025-11-14	MDT	-0.35	-0.40	1.13
2025-11-17	MDT	-0.35	1.15	1.13
2025-11-18	MDT	-0.31	1.15	1.13
2025-11-19	MDT	-0.31	1.15	1.13
2025-11-20	MDT	-0.35	1.15	1.13
2025-11-21	MDT	-3.17	1.15	1.13
2025-11-24	MDT	-3.17	0.36	1.13
2025-11-25	MDT	-3.61	0.36	1.13
2025-11-26	MDT	-3.61	0.36	1.06
2025-12-01	MDT	-3.61	0.07	1.06
2025-12-02	MDT	-3.61	0.07	1.06
2025-12-03	MDT	-3.61	0.07	1.06
2025-12-04	MDT	-3.61	0.07	1.06
2025-12-05	MDT	-3.61	0.07	1.06
2025-12-08	MDT	-3.61	0.65	1.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.36

Avg. EPS Est. Current Quarter

1.34

Avg. EPS Est. Next Quarter

1.69

Insider Transactions

-3.61

Institutional Transactions

0.65

Beta

0.72

Average Sales Estimate Current Quarter

8891

Average Sales Estimate Next Quarter

9631

Fair Value

102.96

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.5

Max Drawdown 5-Year %

-45.1

Target Price

111.12

P/E

27.35

Forward P/E

16.56

PEG

4.49

P/S

3.73

P/B

2.67

P/Free Cash Flow

24.94

EPS

3.7

Average EPS Est. Cur. Y

5.65

EPS Next Y. (Est.)

6.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.71

Relative Volume

0.77

Return on Equity vs Sector %

-17.1

Return on Equity vs Industry %

-8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

ITRM – Iterum Therapeutics Plc

Float Short %

2.64

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.1

EPS Last/This Y

0.67

EPS This/Next Y

0.45

Price

0.45

Target Price

5.5

Analyst Recom

Performance Q

-36.06

Relative Volume

0.64

Beta

2.83

Ticker: ITRM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	ITRM	0.5985	N/A	N/A	0
2025-11-11	ITRM	0.6098	N/A	N/A	0
2025-11-12	ITRM	0.5928	N/A	N/A	0
2025-11-13	ITRM	0.5793	N/A	N/A	0
2025-11-14	ITRM	0.4801	N/A	N/A	0
2025-11-17	ITRM	0.3675	N/A	N/A	0
2025-11-18	ITRM	0.3941	N/A	N/A	0
2025-11-19	ITRM	0.3916	N/A	N/A	0
2025-11-20	ITRM	0.3651	N/A	N/A	0
2025-11-21	ITRM	0.3898	N/A	N/A	0
2025-11-24	ITRM	0.4346	N/A	N/A	0
2025-11-25	ITRM	0.438	N/A	N/A	0
2025-11-26	ITRM	0.4718	N/A	N/A	0
2025-12-01	ITRM	0.4541	N/A	N/A	0
2025-12-02	ITRM	0.419	N/A	N/A	0
2025-12-03	ITRM	0.4214	N/A	N/A	0
2025-12-04	ITRM	0.4474	N/A	N/A	0
2025-12-05	ITRM	0.4675	N/A	N/A	0
2025-12-08	ITRM	0.4482	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	ITRM	0.60	-	-	-0.33
2025-11-11	ITRM	0.61	-	-	-0.33
2025-11-12	ITRM	0.59	-	-	-0.33
2025-11-13	ITRM	0.58	-	-	-0.33
2025-11-14	ITRM	0.48	-	-	-0.33
2025-11-17	ITRM	0.37	-	-	-0.33
2025-11-18	ITRM	0.40	-	-	-0.33
2025-11-19	ITRM	0.38	-	-	-0.33
2025-11-20	ITRM	0.37	-	-	-0.33
2025-11-21	ITRM	0.39	-	-	-0.33
2025-11-24	ITRM	0.43	-	-	-0.59
2025-11-25	ITRM	0.44	-	-	-0.59
2025-11-26	ITRM	0.47	-	-	-0.59
2025-12-01	ITRM	0.45	-	-	-0.59
2025-12-02	ITRM	0.41	-	-	-0.59
2025-12-03	ITRM	0.42	-	-	-0.59
2025-12-04	ITRM	0.45	-	-	-0.59
2025-12-05	ITRM	0.47	-	-	-0.59
2025-12-08	ITRM	0.45	-	-	-0.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	ITRM	1.45	3.05	2.43
2025-11-11	ITRM	1.88	3.05	2.43
2025-11-12	ITRM	1.88	3.05	2.86
2025-11-13	ITRM	1.88	3.05	2.86
2025-11-14	ITRM	2.02	3.05	2.86
2025-11-17	ITRM	2.02	2.94	2.86
2025-11-18	ITRM	2.02	2.94	2.86
2025-11-19	ITRM	2.02	2.94	2.86
2025-11-20	ITRM	2.58	2.94	2.86
2025-11-21	ITRM	2.58	2.94	0
2025-11-24	ITRM	4.85	-2.41	2.58
2025-11-25	ITRM	4.79	-2.41	2.58
2025-11-26	ITRM	4.79	-2.41	2.64
2025-12-01	ITRM	4.79	-2.21	2.64
2025-12-02	ITRM	4.79	-2.21	2.64
2025-12-03	ITRM	4.79	-2.21	2.64
2025-12-04	ITRM	4.79	-2.21	2.64
2025-12-05	ITRM	4.79	-2.21	2.64
2025-12-08	ITRM	4.79	-2.22	2.64
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

4.79

Institutional Transactions

-2.22

Beta

2.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.9

Max Drawdown 5-Year %

-99

Target Price

5.5

P/E

Forward P/E

PEG

P/S

60.68

P/B

P/Free Cash Flow

EPS

-0.75

Average EPS Est. Cur. Y

-0.59

EPS Next Y. (Est.)

-0.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6913.08

Relative Volume

0.64

Return on Equity vs Sector %

338.4

Return on Equity vs Industry %

353.3

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.26

EBIT Estimation

Iterum Therapeutics plc

Sector: Healthcare

Industry: Biotechnology

Employees: 9

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today

news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance

stock history ITRM – Iterum Therapeutics Plc invest stock market

stock prices ITRM premarket after hours

ticker ITRM fair value insiders trading

AMRN – Amarin Corp ADR

Float Short %

1.91

Margin Of Safety %

Put/Call OI Ratio

0.3

EPS Next Q Diff

EPS Last/This Y

4.22

EPS This/Next Y

0.37

Price

14.92

Target Price

Analyst Recom

Performance Q

-1.97

Relative Volume

1.51

Beta

0.72

Ticker: AMRN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	AMRN	15.89	0.32	0.00	8694
2025-11-11	AMRN	16.16	0.32	0.00	8815
2025-11-12	AMRN	16.19	0.31	0.00	8948
2025-11-13	AMRN	16.33	0.31	0.24	9023
2025-11-14	AMRN	16.32	0.30	0.03	9192
2025-11-17	AMRN	16.11	0.30	2.50	9204
2025-11-18	AMRN	16.74	0.31	0.87	9239
2025-11-19	AMRN	16.97	0.32	0.17	9531
2025-11-20	AMRN	16.39	0.32	0.05	9663
2025-11-21	AMRN	16.37	0.31	2.57	9858
2025-11-24	AMRN	15.88	0.35	0.11	7144
2025-11-25	AMRN	15.7	0.35	0.27	7311
2025-11-26	AMRN	16.18	0.35	0.04	7370
2025-12-01	AMRN	15.62	0.32	0.11	7907
2025-12-02	AMRN	15.62	0.32	0.10	7926
2025-12-03	AMRN	16.29	0.32	0.04	7967
2025-12-04	AMRN	16.53	0.31	0.12	8191
2025-12-05	AMRN	16.5	0.31	0.00	8210
2025-12-08	AMRN	14.94	0.30	0.36	8361
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	AMRN	15.85	117.5	-	0.22
2025-11-11	AMRN	16.09	117.5	-	0.22
2025-11-12	AMRN	16.13	117.5	-	0.22
2025-11-13	AMRN	16.25	117.5	-	0.22
2025-11-14	AMRN	16.33	117.5	-	0.22
2025-11-17	AMRN	16.05	117.5	-	0.22
2025-11-18	AMRN	16.75	117.5	-	0.22
2025-11-19	AMRN	16.98	117.5	-	0.22
2025-11-20	AMRN	16.42	117.5	-	0.22
2025-11-21	AMRN	16.34	117.5	-	0.22
2025-11-24	AMRN	15.88	117.5	-	0.22
2025-11-25	AMRN	15.72	117.5	-	0.22
2025-11-26	AMRN	16.09	117.5	-	0.22
2025-12-01	AMRN	15.59	117.5	-	0.22
2025-12-02	AMRN	15.53	117.5	-	0.22
2025-12-03	AMRN	16.29	117.5	-	0.22
2025-12-04	AMRN	16.48	117.5	-	0.22
2025-12-05	AMRN	16.54	117.5	-	0.22
2025-12-08	AMRN	14.92	117.5	-	0.22
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	AMRN	0.00	0.64	1.65
2025-11-11	AMRN	0.00	0.64	1.65
2025-11-12	AMRN	0.00	0.64	1.79
2025-11-13	AMRN	0.00	0.64	1.79
2025-11-14	AMRN	0.00	0.64	1.79
2025-11-17	AMRN	0.00	1.47	1.79
2025-11-18	AMRN	0.00	1.47	1.79
2025-11-19	AMRN	0.00	1.47	1.79
2025-11-20	AMRN	0.00	1.47	1.79
2025-11-21	AMRN	0.00	1.47	1.79
2025-11-24	AMRN	0.00	3.16	1.79
2025-11-25	AMRN	0.00	3.16	1.79
2025-11-26	AMRN	0.00	3.16	1.91
2025-12-01	AMRN	0.00	3.15	1.91
2025-12-02	AMRN	0.00	3.15	1.91
2025-12-03	AMRN	0.00	3.15	1.91
2025-12-04	AMRN	0.00	3.15	1.91
2025-12-05	AMRN	0.00	3.15	1.91
2025-12-08	AMRN	0.00	3.15	1.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.07

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

3.15

Beta

0.72

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.9

Max Drawdown 5-Year %

-95.5

Target Price

P/E

Forward P/E

104.27

PEG

P/S

1.37

P/B

0.68

P/Free Cash Flow

EPS

-4.17

Average EPS Est. Cur. Y

0.22

EPS Next Y. (Est.)

0.59

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-37.87

Relative Volume

1.51

Return on Equity vs Sector %

-45.7

Return on Equity vs Industry %

-55.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 275

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

ALKS – Alkermes plc

Float Short %

10.71

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

-0.11

EPS Last/This Y

-0.29

EPS This/Next Y

0.23

Price

29.41

Target Price

43.88

Analyst Recom

1.44

Performance Q

5.6

Relative Volume

0.7

Beta

0.48

Ticker: ALKS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	ALKS	32.65	0.42	1.35	18653
2025-11-11	ALKS	33.81	0.43	0.13	18904
2025-11-12	ALKS	31.39	0.41	1.75	19740
2025-11-13	ALKS	31.03	0.44	1.56	20631
2025-11-14	ALKS	29.03	0.44	0.17	20673
2025-11-17	ALKS	29.33	0.40	0.09	23442
2025-11-18	ALKS	29.23	0.41	0.64	23252
2025-11-19	ALKS	28.7	0.41	0.62	23269
2025-11-20	ALKS	28.2	0.40	0.79	23149
2025-11-21	ALKS	28.6	0.40	1.63	23058
2025-11-24	ALKS	28.21	0.63	0.18	11109
2025-11-25	ALKS	29.01	0.63	0.21	11156
2025-11-26	ALKS	29.71	0.62	0.02	11462
2025-12-01	ALKS	28.89	0.70	6.50	10780
2025-12-02	ALKS	28.97	0.70	0.48	10821
2025-12-03	ALKS	29.53	0.70	0.12	10825
2025-12-04	ALKS	29.38	0.70	1.44	10828
2025-12-05	ALKS	29.52	0.70	1.05	10842
2025-12-08	ALKS	29.42	0.71	0.00	10867
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	ALKS	32.65	-59.4	-82.2	1.95
2025-11-11	ALKS	33.81	-59.4	-64.6	1.95
2025-11-12	ALKS	31.40	-59.4	-107.8	1.95
2025-11-13	ALKS	30.99	-59.4	-84.5	1.95
2025-11-14	ALKS	29.02	-59.4	-105.4	1.95
2025-11-17	ALKS	29.33	-61.7	-74.8	1.93
2025-11-18	ALKS	29.24	-61.7	-80.4	1.93
2025-11-19	ALKS	28.69	-61.7	-87.3	1.93
2025-11-20	ALKS	28.20	-61.7	-86.4	1.93
2025-11-21	ALKS	28.60	-61.7	-73.1	1.93
2025-11-24	ALKS	28.20	-61.7	-85.0	1.93
2025-11-25	ALKS	28.99	-61.7	-67.3	1.93
2025-11-26	ALKS	29.72	-61.7	-68.6	1.93
2025-12-01	ALKS	28.90	-61.7	-88.6	1.93
2025-12-02	ALKS	28.97	-61.7	-78.1	1.93
2025-12-03	ALKS	29.53	-61.7	-71.1	1.93
2025-12-04	ALKS	29.30	-61.7	-82.4	1.93
2025-12-05	ALKS	29.52	-61.7	-76.0	1.93
2025-12-08	ALKS	29.41	-61.7	-	1.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	ALKS	-0.60	-1.27	8.94
2025-11-11	ALKS	-0.60	-1.27	8.94
2025-11-12	ALKS	-0.60	-1.27	9.87
2025-11-13	ALKS	-0.60	-1.27	9.87
2025-11-14	ALKS	-0.60	-1.27	9.87
2025-11-17	ALKS	-0.61	0.64	9.87
2025-11-18	ALKS	-0.61	0.64	9.87
2025-11-19	ALKS	-0.61	0.64	9.87
2025-11-20	ALKS	-0.61	0.64	9.87
2025-11-21	ALKS	-0.61	0.64	9.87
2025-11-24	ALKS	-0.61	1.23	9.85
2025-11-25	ALKS	-0.66	1.23	9.85
2025-11-26	ALKS	-0.66	1.23	10.71
2025-12-01	ALKS	-0.66	1.28	10.71
2025-12-02	ALKS	-0.77	1.28	10.71
2025-12-03	ALKS	-0.77	1.28	10.71
2025-12-04	ALKS	-0.77	1.28	10.71
2025-12-05	ALKS	-0.87	1.28	10.71
2025-12-08	ALKS	-0.87	1.22	10.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.49

Avg. EPS Est. Current Quarter

0.4

Avg. EPS Est. Next Quarter

0.38

Insider Transactions

-0.87

Institutional Transactions

1.22

Beta

0.48

Average Sales Estimate Current Quarter

378

Average Sales Estimate Next Quarter

378

Fair Value

34.66

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

19.3

Max Drawdown 5-Year %

-33.2

Target Price

43.88

P/E

14.55

Forward P/E

17.93

PEG

P/S

3.19

P/B

2.8

P/Free Cash Flow

9.89

EPS

2.02

Average EPS Est. Cur. Y

1.93

EPS Next Y. (Est.)

2.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

22.27

Relative Volume

0.7

Return on Equity vs Sector %

-7.3

Return on Equity vs Industry %

12.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

Alkermes plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1800

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

stock quote shares ALKS – Alkermes plc Stock Price stock today

news today ALKS – Alkermes plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ALKS – Alkermes plc yahoo finance google finance

stock history ALKS – Alkermes plc invest stock market

stock prices ALKS premarket after hours

ticker ALKS fair value insiders trading

TT – Trane Technologies plc

Float Short %

1.24

Margin Of Safety %

-12

Put/Call OI Ratio

0.62

EPS Next Q Diff

-1.18

EPS Last/This Y

1.68

EPS This/Next Y

1.84

Price

397.27

Target Price

483.96

Analyst Recom

2.58

Performance Q

-2.97

Relative Volume

1.29

Beta

1.21

Ticker: TT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	TT	433.55	0.73	0.33	9071
2025-11-11	TT	421.53	0.73	0.03	9125
2025-11-12	TT	421.74	0.73	0.08	9106
2025-11-13	TT	415.02	0.68	0.93	9556
2025-11-14	TT	418.41	0.69	0.30	9605
2025-11-17	TT	412.25	0.69	2.65	9641
2025-11-18	TT	407.1	0.71	0.44	9769
2025-11-19	TT	406.71	0.68	0.71	9988
2025-11-20	TT	399.82	0.68	0.76	10028
2025-11-21	TT	410.21	0.66	0.82	9973
2025-11-24	TT	409.83	0.66	0.51	8048
2025-11-25	TT	418.87	0.66	0.48	8113
2025-11-26	TT	419.48	0.65	0.21	8170
2025-12-01	TT	410.16	0.63	0.65	8427
2025-12-02	TT	411.21	0.63	0.12	8461
2025-12-03	TT	408.82	0.63	0.56	8486
2025-12-04	TT	405.27	0.63	0.15	8518
2025-12-05	TT	401.27	0.64	0.14	8498
2025-12-08	TT	397.34	0.62	0.08	8714
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	TT	433.50	7.9	485.7	13.03
2025-11-11	TT	421.64	8.0	378.9	13.02
2025-11-12	TT	421.86	8.0	497.8	13.02
2025-11-13	TT	414.89	8.0	426.3	13.02
2025-11-14	TT	418.09	8.0	528.7	13.02
2025-11-17	TT	413.79	8.0	451.0	13.01
2025-11-18	TT	406.95	8.0	425.3	13.01
2025-11-19	TT	406.83	8.0	493.3	13.01
2025-11-20	TT	399.93	8.0	423.4	13.01
2025-11-21	TT	410.21	8.0	603.2	13.01
2025-11-24	TT	409.88	8.0	493.2	13.01
2025-11-25	TT	418.82	8.0	587.6	13.01
2025-11-26	TT	419.45	8.0	501.9	13.01
2025-12-01	TT	410.21	8.0	381.7	13.03
2025-12-02	TT	411.22	8.0	506.5	13.03
2025-12-03	TT	409.07	8.0	473.2	13.03
2025-12-04	TT	405.20	8.0	455.3	13.03
2025-12-05	TT	401.43	8.0	454.4	13.03
2025-12-08	TT	397.27	8.0	-	13.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	TT	-4.23	-0.07	1.33
2025-11-11	TT	-4.07	-0.07	1.33
2025-11-12	TT	-4.07	-0.07	1.40
2025-11-13	TT	-4.07	-0.07	1.40
2025-11-14	TT	-4.07	-0.07	1.40
2025-11-17	TT	-4.07	1.83	1.40
2025-11-18	TT	-3.78	1.83	1.40
2025-11-19	TT	-4.07	1.83	1.40
2025-11-20	TT	-4.07	1.83	1.40
2025-11-21	TT	-4.07	1.83	1.40
2025-11-24	TT	-3.53	-0.80	1.40
2025-11-25	TT	-4.23	-0.80	1.40
2025-11-26	TT	-4.23	-0.80	1.24
2025-12-01	TT	-4.23	-0.84	1.24
2025-12-02	TT	-4.23	-0.84	1.24
2025-12-03	TT	-4.23	-0.84	1.24
2025-12-04	TT	-4.23	-0.84	1.24
2025-12-05	TT	-4.23	-0.84	1.24
2025-12-08	TT	-4.23	-0.85	1.24
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

3.88

Avg. EPS Est. Current Quarter

2.82

Avg. EPS Est. Next Quarter

2.7

Insider Transactions

-4.23

Institutional Transactions

-0.85

Beta

1.21

Average Sales Estimate Current Quarter

5097

Average Sales Estimate Next Quarter

4921

Fair Value

351.17

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.6

Max Drawdown 5-Year %

-40.5

Target Price

483.96

P/E

30.57

Forward P/E

26.76

PEG

2.13

P/S

4.18

P/B

10.59

P/Free Cash Flow

34.52

EPS

12.99

Average EPS Est. Cur. Y

13.03

EPS Next Y. (Est.)

14.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.93

Relative Volume

1.29

Return on Equity vs Sector %

17.7

Return on Equity vs Industry %

14.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Trane Technologies plc

Sector: Industrials

Industry: Building Products & Equipment

Employees: 45000

Trane Technologies plc designs, manufactures, sells, and services of solutions for heating, ventilation, air conditioning, and custom and transport refrigeration. It offers air conditioners, exchangers, and handlers; airside and terminal devices; air sourced heat pumps; chillers; coils and condensers; auxiliary power, cold storage, cold storage, and condensing units; controls contracting and commissioning, decarbonization programs, and gensets; dehumidifiers; energy and water efficiency programs; energy recovery ventilators; energy storage; furnaces; home automation; humidifiers; HVAC performance-monitoring products; and indoor air quality assessments and related products for HVAC and transport solutions. The company also provides asset management, building management, bus air purification, bus and rail HVAC, container refrigeration, control, cryogenic refrigeration, ductless, geothermal, data center and multi-pipe HVAC, package heating and cooling, rail refrigeration, residential air filtration, self-powered truck refrigeration, temporary heating and cooling, truck refrigeration, unitary, variable refrigerant flow, and trailer refrigeration systems. In addition, it offers industrial process refrigeration, installation contracting, lighting retrofit, medical grade refrigeration, refrigerant reclamation, renewable energy and storage, residential hybrid heating, telematics, thermostats/controls and associated digital, and ventilation solutions; packaged rooftop units; rate chambers; residential air filters; thermal energy storage; transport heater products; ultra-low temperature freezers; energy infrastructure programs and management, repair and maintenance, smart and AI-enabled, and rental services; and water source heat pumps, as well as aftermarket and OEM parts and supplies. The company was formerly known as Ingersoll-Rand Plc and changed its name to Trane Technologies plc in March 2020. The company was founded in 1885 and is headquartered in Swords, Ireland.

stock quote shares TT – Trane Technologies plc Stock Price stock today

news today TT – Trane Technologies plc stock forecast ,stock prediction 2023 2024 2025

marketwatch TT – Trane Technologies plc yahoo finance google finance

stock history TT – Trane Technologies plc invest stock market

stock prices TT premarket after hours

ticker TT fair value insiders trading

No more stocks to show

MURA – Mural Oncology plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MURA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

MDT – Medtronic Plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MDT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y